Team releases gene edited human stem cell lines

November 30, 2016, Allen Institute for Brain Science
A cluster of human induced pluripotent stem cells (hiPSCs) highlighted with dyes that detail cell membranes (purple) and DNA in the nucleus (blue). Spindles from microtubules (white), seen in the center of the image, aid in cell division. Credit: Allen Institute for Cell Science

The Allen Institute for Cell Science has released the Allen Cell Collection: the first publicly available collection of gene edited, fluorescently tagged human induced pluripotent stem cells that target key cellular structures with unprecedented clarity.

Distributed through the Coriell Institute for Medical Research, these powerful tools are a crucial first step toward visualizing the dynamic organization of cells to better understand what makes human cells healthy and what goes wrong in disease.

"Each of our cells—the fundamental units of life—are like a city, with people and resources that move around and factories that generate those resources and carry out important functions," says Rick Horwitz, Ph.D., Executive Director of the Allen Institute for Cell Science. "With these , we aim to give the community a kind of live traffic map to see when and where the parts of the cell are with the clarity and consistency they need to make progress toward understanding human health and tackling disease."

Scientists at the Allen Institute for Cell Science used CRISPR/Cas9 technology to insert fluorescent tags for major into human induced pluripotent stem cells. Unlike typical methods which flood the cell with fluorescent protein, these highly precise tags show exactly when and where the structures are at various stages in the cell's lifecycle.

High-magnification timelapse movie of a hiPSC colony expressing alpha tubulin-mEGFP; a fluorescent tag on microtubules -- a component of the cell's inner skeleton. Images taken in 3-D every 1 minute for 65 minutes. Image is a maximum intensity projection Movie sped up 900x over real time. Credit: Allen Institute for Cell Science

"By lowering the barrier to entry for cell biologists wishing to work on iPS cells, the availability of these lines will usher in a new era in cell biology," says Anthony Hyman, Ph.D., Director and Group Leader at the Max Planck Institute of Molecular Cell Biology and Genetics.

This first collection of five cell lines targets a set of major cellular structures that help to orient the cell. These include the nucleus (tagged by the protein lamin B1), mitochondria (Tom20), microtubules (alpha-tubulin), cell-to-cell junctions (desmoplakin) and adhesion (paxillin). Subsequent collections will be released throughout 2017.

"This kind of precise fluorescent tagging of structures in human is valuable for a variety of reasons, not least of which is that the can be turned into a large number of cell types, like heart, brain or skin," says Ruwanthi Gunawardane, Ph.D., Director of Stem Cells and Gene Editing at the Allen Institute for Cell Science. "Our cells are healthy and as close to normal human cells as we can study in the lab, making these cell lines a powerful platform to identify the functions of genes, screen drugs, determine differentiation state and much more."

Learn about the Allen Cell Collection: The first publicly available collection of gene edited, fluorescently tagged human induced pluripotent stem cells. Credit: Allen Institute for Cell Science

"With these tagged cell lines, we get to 'spy' on the organization of healthy, normal in a way that scientists never could before," says Susanne Rafelski, Ph.D., Director of Assay Development at the Allen Institute for Cell Science. "The images and movies we can generate from these lines show the cell's major structures with astonishing clarity and empower a broad, multi-structure view of how cells change as they execute their various activities and turn into different kinds of cells."

The cell lines will be available for scientists around the world to use not just to understand the fundamentals of the cell, but also to investigate disease. Key mutations can be introduced to the in order to study how disease progresses in a dish, with broad potential impacts on the fields of biomedical science and personalized medicine.

Explore further: Microsoft's Paul Allen gives $100 million to disease research

Related Stories

Microsoft's Paul Allen gives $100 million to disease research

December 8, 2014
Microsoft co-founder and philanthropist Paul Allen on Monday announced he was giving $100 million to create a disease research institute in Seattle, Washington.

Stem cell study finds source of earliest blood cells during development

March 21, 2014
Hematopoietic stem cells are now routinely used to treat patients with cancers and other disorders of the blood and immune systems, but researchers knew little about the progenitor cells that give rise to them during embryonic ...

Donor's genotype controls the differentiation of iPS cells—source tissue insignificant

January 14, 2016
Pluripotent stem cells derived from different cell types are equally susceptible to reprogramming, indicates a recent study.

Are embryonic stem cells and artificial stem cells equivalent?

October 29, 2015
Harvard Stem Cell Institute (HSCI) researchers at Massachusetts General Hospital and Harvard Medical School have found new evidence suggesting some human induced pluripotent stem cells are the 'functional equivalent' of human ...

International initiative to address safety issues in stem cell therapy

November 28, 2011
An international study, published today in the prestigious journal Nature Biotechnology, reveals more about human pluripotent stem cells and their genetic stability and has important implications for the development of therapies ...

Researchers gather for stem cell retreat

November 8, 2013
Scientists from across the state are gathering for a retreat at the Health Center today to present their latest findings in the field of stem cell research. Among those making presentations include researchers from UConn, ...

Recommended for you

Critical role of DHA on foetal brain development revealed

August 17, 2018
Duke-NUS researchers have found evidence that a natural form of Docosahexaenoic Acid (DHA) made by the liver called Lyso-Phosphatidyl-Choline (LPC-DHA), is critical for normal foetal and infant brain development, and that ...

New algorithm could improve diagnosis of rare diseases

August 17, 2018
Today, diagnosing rare genetic diseases requires a slow process of educated guesswork. Gill Bejerano, Ph.D., associate professor of developmental biology and of computer science at Stanford, is working to speed it up.

Gene silencing critical for normal breast development

August 17, 2018
Researchers have discovered that normal breast development relies on a genetic 'brake', a protein complex that keeps swathes of genes silenced.

Officials remove special rules for gene therapy experiments

August 16, 2018
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks.

Genetic link discovered between circadian rhythms and mood disorders

August 15, 2018
Circadian rhythms are regular 24-hour variations in behaviour and activity that control many aspects of our lives, from hormone levels to sleeping and eating habits.

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.